pulsebiosciences.com (PLSE) Expected earnings per share growth for next year
Pulse Biosciences, Inc. (PLSE) is demonstrating steady growth in physician loyalty driven by innovation. The history of earnings per share (EPS) expectation revisions confirms this trajectory, with the metric recorded at -9.30. Development relies on non-thermal tissue ablation for tumor treatment. Key catalysts include FDA approvals and the launch of commercial sales for cardiology catheters.
Analytical breakdowns for Pulse Biosciences (PLSE)
- share price and consensus valuation forecast:
- market capitalization details:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Pulse Medical|PLSE - Company Total Debt Obligations|Debts to Book Capitalization Pulse Corp|PLSE - Company Long-Term Liabilities|Company Short-Term Debts Pulse Biosciences|Quick Liquidity pulsebiosciences.com
- net income and valuation ratios data:
PLSE - Company Net Income|Future Profit Pulse Biosciences, Inc.|PLSE - Company Value to Net Income|Forward P/E Multiple Pulse Medical|PLSE - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pulse Biosciences Inc|PLSE - Operating profit before depreciation charges|Net earnings per share for the last 12 months Pulse Biosciences|PLSE - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth pulsebiosciences.com|PLSE - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Pulse Biosciences, Inc.
- sales volume and revenue indicators:
Initial company analysis:pulsebiosciences.com, PLSE
The price action of Pulse Biosciences, Inc. (PLSE), as reflected by the expected annual EPS growth rate for the coming year, captures daily changes in the analysts' consensus earnings forecast. This indicator measures market expectations regarding management's ability to optimize expenses and avoid cash flow gaps, which is critical for the company during a period of high operating costs for clinical trials and the anticipation of FDA approval.
Analysis of competing companies
DXCM (dexcom.com) - Earnings growth forecast for next year|PEN: Expected earnings per share trend next year|Expected earnings per share growth for next year NOVT (Novanta)|Expected earnings per share growth for next year Haemonetics HAE|Net earnings per share growth forecast for next year Inspire Medical Systems Inc INSP|PRCT - Expected earnings per share growth for next year|CONMED Corp - Earnings growth forecast for next year|Expected net earnings per share growth next year InMode Ltd.|PMI: Earnings growth forecast for next year|Projected earnings per share growth rate for next year SRDX|SENS (Senseonics Corp) - Earnings growth forecast for next year|NeuroPace Corp (NPCE) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year TCMD|Expected earnings per share growth for next year Sanuwave Health Inc SNWV|Outset Medical - Expected earnings per share growth for next year|Earnings growth forecast for next year Electromed, Inc. ELMD|LNSR - Net earnings per share growth forecast for next year|RCEL: Net earnings per share growth forecast for next year|PROF (Profound Medical Corporation) - Expected earnings per share growth for next year|Baird Medical Investment Holdings - Expected earnings per share trend next year|EDAP (EDAP TMS SA) - Earnings growth forecast for next year|Expected net earnings per share growth next year apyxmedical.com APYX|Net earnings per share growth forecast for next year IceCure Medical (ICCM)|Pulmonx Corp. (LUNG) - Net earnings per one share growth forecast for next year|TELA Bio Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year CytoSorbents Corp. CTSO|Sensus Healthcare Inc - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Zynex Medical ZYXI|electroCore (ECOR) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year RBOT (Vicarious Surgical Corp)|Net earnings per share growth forecast for next year inspira-technologies.com|Expected net earnings per share growth next year seastarmedical.com ICU|Earnings growth forecast for next year IRIX|INBS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year beyondair.net XAIR|PFSA: Projected earnings per share growth rate for next year|SSKN: Expected earnings per share growth for next year|GlucoTrack - Projected earnings per share increase next year|NanoVibronix (NAOV) - Net earnings per share growth forecast for next year|VERO (Venus Concept) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year NUWE|Expected net earnings per share growth next year Aethlon Medical AEMD|Earnings growth forecast for next year ASXC|Consensus forecast of earnings per share growth for next year avinger.com|Net earnings per share growth forecast for next year BioSig Technologies Inc. BSGM|Cutera Inc. (CUTR) - Expected net earnings per share growth next year|KNW - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Inari Medical, Inc. NARI|NVRO (Nevro Corp.) - Expected earnings per share growth for next year|Net earnings per share change forecast for next year RSLS (ReShape Lifesciences, Inc.)|Net earnings per share growth forecast for next year Silk Road Medical Inc
